Vasopressor therapy using vasopressin prior to crystalloid resuscitation in irreversible hemorrhagic shock under isoflurane anesthesia in dogs

Journal of Veterinary Medical Science

Volumn 69, Issue 5, 2007, Pages 459-464

  Yoo, Jong Hyun ^a   Kim, Min Su ^a   Eom, Ki Dong ^b   Park, Jong Im ^b   Park, Chul ^b   Park, Hee Myung ^b  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Canine; Fluid resuscitation; Hemorrhagic shock; Vasopressin

Indexed keywords

CRYSTALLOID SOLUTIONS; ISOFLURANE; ISOTONIC SOLUTION; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD PRESSURE; DOG; DOG DISEASE; DRUG EFFECT; HEART OUTPUT; HEMORRHAGIC SHOCK; OXYGEN CONSUMPTION; RESUSCITATION; VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; DOG DISEASES; DOGS; ISOFLURANE; ISOTONIC SOLUTIONS; OXYGEN CONSUMPTION; RESUSCITATION; SHOCK, HEMORRHAGIC; VASCULAR RESISTANCE; VASOPRESSINS;

CANIS FAMILIARIS;

EID: 34249996785     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.69.459     Document Type: Article

References (23)

1. Abboud, F. M., Floras, J. S., Aylward, P. E., Guo, G. B., Gupta, B. N. and Schmid, P. G. 1990. Role of vasopressin in cardiovascular and blood pressure regulation. Blood Vessels 27: 106-115.
2. Blinman, T. and Maggard, M. 2000. Rational manipulation of oxygen delivery. J. Surg. Res. 92: 120-141.
3. Boag, A.K. and Hughes, D. 2005. Assessment and treatment of perfusion abnormalities in the emergency patient. Vet. Clin. North Am. Small Anim. Pract. 35: 319-342.
4. Cervera, A.L. and Moss, G. 1975. Progressive hypovolemia leading to shock after continuous hemorrhage and 3:1 crystalloid replacement. Am. J. Surg. 129: 670-674.
5. DiBartola, S.P. 2000. pp. 428-448. Fluid Therapy in Small Animal Practice. 2nd ed., Philadelphia, PA, WB Saunders.
6. Garcia-Villalon, A.L., Garcia, J.L., Fernandez, N., Monge, L., Gomez, B., and Dieguez, G. 1996. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br. J. Pharmacol. 118: 1848-1854.
7. Glick, Y.A., Wilson, L.D. and Aiello, J. 2002. Hematocrit and metabolic changes caused by varied resuscitation strategies in a canine model of hemorrhagic shock. Am. J. Emerg. Med. 20: 303-309.
8. Hollenberg, S.M., Ahrens, T.S., Annane, D., Astiz, M.E., Chalfin, D.B., Dasta, J.F., Heard, S.O., Martin, C., Napolitano, L.M., Susla, G.M., Totaro, R., Vincent, J.L. and Zanotti-Cavazzoni, S. 2004. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit. Care. Med. 32: 1928-1948.
9. Johnson, T. 2003. Use of Vasopressin in Cardiopulmonary Arrest: Controversy and Promise. Compend. Cont. Educ. Pract. Vet. 6: 448-451.
10. Kellum, J.A. and Pinsky, M.R. 2002. Use of vasopressor agents in critically ill patients. Curr. Opin. Crit. Care 8: 236-241.
11. Krismer, A.C., Wenzel, V., Mayr, V.D., Voelckel, W.G., Strohmenger ,H.U., Lurie, K. and Lindner, K.H. 2001. Arginine vasopressin during cardiopulmonary resuscitation and vasodilatory shock: current experience and future perspectives. Curr. Opin. Crit. Care 7: 157-169.
12. Mellema, M. 2001. Cardiac output, wedge pressure, and oxygen delivery. Vet. Clin. North Am. Small Anim. Pract. 31: 1175-1205.
13. Morales, D., Madigan, J., Cullinane, S., Chen, J., Heath, M., Oz, M., Oliver, J.A. and Landry, D.W. 1999. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 100: 226-229.
14. Priebe, H.J. 1987. Differential effects of isoflurane on regional right and left ventricular performances, and on coronary, systemic, and pulmonary hemodynamics in the dog. Anesthesiology 66: 262-272.
15. Rudichenko, V.M. and Beierwaltes, W.H. 1995. Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J. Vasc. Res. 32: 100-105.
16. Shoemaker, W.C. 1987. Circulatory mechanisms of shock and their mediators. Crit. Care Med. 15: 787-794.
17. Solomonov, E., Hirsh, M., Yahiya, A. and Krausz, M.M. 2000. The effect of vigorous fluid resuscitation in uncontrolled hemorrhagic shock after massive splenic injury. Crit. Care Med. 28: 749-754.
18. Stadlbauer, K.H., Wagner-Berger, H.G., Raedler, C., Voelckel, W.G., Wenzel, V., Krismer, A.C., Klima, G., Rheinberger, K., Nussbaumer, W., Pressmar, D., Lindner, K.H. and Konigsrainer, A. 2003. Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiology 98: 699-704.
19. Thiemermann, C., Szabo, C., Mitchell, J.A. and Vane, J.R. 1993. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 90: 267-271.
20. Tomiyasu, S., Hara, T., Hasuo, H., Ureshino, H. and Sumikawa, K. 1999. Comparative analysis of systemic and coronary hemodynamics during sevoflurane- and isoflurane-induced hypotension in dogs. J. Cardiovasc. Pharmacol. 33: 741-747.
21. Vanhoutte, P.M., Katusic, Z.S. and Shepherd, J.T. 1984. Vasopressin induces endothelium-dependent relaxations of cerebral and coronary, but not of systemic arteries. J. Hypertens. (Suppl.) 2: S421-S422.
22. Voelckel, W.G., Lurie, K.G., Lindner, K.H., Zielinski, T., McKnite, S., Krismer, A.C. and Wenzel, V. 2000. Vasopressin improves survival after cardiac arrest in hypovolemic shock. Anesth. Analg. 91: 627-634.
23. Walker, B.R., Haynes, J. Jr., Wang, H.L. and Voelkel, N.F. 1989. Vasopressin-induced pulmonary vasodilation in rats. Am. J. Physiol. 257: H415-H422.